Scoping review of guidance on cessation interventions for electronic cigarettes and dual electronic and combustible cigarettes use

Abstract

Background: Although evidence-based smoking cessation guidelines are available, the applicability of these guidelines for the cessation of electronic cigarette and dual e-cigarette and combustible cigarette use is not yet established. In this review, we aimed to identify current evidence or recommendations for cessation interventions for e-cigarette users and dual users tailored to adolescents, youth and adults, and to provide direction for future research. Methods: We systematically searched MEDLINE, Embase, PsycINFO and grey literature for publications that provided evidence or recommendations on vaping cessation for e-cigarette users and complete cessation of cigarette and e-cigarette use for dual users. We excluded publications focused on smoking cessation, harm reduction by e-cigarettes, cannabis vaping, and management of lung injury associated with e-cigarette or vaping use. Data were extracted on general characteristics and recommendations made in the publications, and different critical appraisal tools were used for quality assessment. Results: A total of 13 publications on vaping cessation interventions were included. Most articles were youth-focused, and behavioural counselling and nicotine replacement therapy were the most recommended interventions. Whereas 10 publications were appraised as “high quality” evidence, 5 articles adapted evidence from evaluation of smoking cessation. No study was found on complete cessation of cigarettes and e-cigarettes for dual users. Interpretation: There is little evidence in support of effective vaping cessation interventions and no evidence for dual use cessation interventions. For an evidence-based cessation guideline, clinical trials should be rigorously designed to evaluate the effectiveness of behavioural interventions and medications for e-cigarette and dual use cessation among different subpopulations.

Assessing the Quality and Behavior Change Potential of Vaping Cessation Apps: Systematic Search and Assessment

“…Individuals may seek out assistance and advice from their health care providers when considering vaping cessation. While the treatment approaches for tobacco cessation are long established, there is little guidance relating to vaping cessation [ 36 ] nor are there evidence-based clinical guidelines on cessation of dual use (the use of both vapes and tobacco cigarettes) [ 37 ]. The Canadian Paediatric Society recently provided preliminary clinical guidance on e-cigarette cessation for young people [ 38 ].…”

Regulation of endothelial function by cigarette smoke and next-generation tobacco and nicotine products

“…A recent meta-analysis suggest among patients who attempt to quit smoking, e-cigarettes might be more efficacious than conventional nicotine replacement or behavioral smoking cessation therapies [ 60 ]. However, there is currently little evidence supporting effective vaping cessation interventions and no evidence for dual use cessation interventions [ 54 ].…”

Clinical guidance for e-cigarette (vaping) cessation: Results from a modified Delphi panel approach

“…We first conducted a scoping review to identify evidence-based e-cigarette and dual use cessation interventions and guidance for youth, adolescents and adults published between 2010 and August 2021. We screened 508 records and included 12 papers in the final published review ( Kundu et al, 2023 ).…”

“…While treatment approaches for tobacco cessation are well established, there are currently no evidence-based clinical guidelines available for e-cigarette or vaping cessation. We recently undertook a scoping review of current recommendations for e-cigarette and dual electronic and tobacco cigarette cessation in adults and youth, and found limited evidence-informed guidance on effective cessation interventions ( Kundu et al, 2023 ). Given the increase of e-cigarette use and the lack of published clinical guidance for e-cigarette and dual use cessation, we developed an expert informed clinical guidance resource to help adults and youth (ages 15 to 24) quit using e-cigarettes.…”